US will pay vaccine maker Moderna $176 million to develop an mRNA-based pandemic flu vaccine
US will pay vaccine maker Moderna $176 million to develop an mRNA-based pandemic flu vaccine
By Ap News
Published - Jul 02, 2024, 10:30 AM ET
Last Updated - Jul 02, 2024, 10:30 AM EDT
WASHINGTON (AP) — US will pay vaccine maker Moderna $176 million to develop an mRNA-based pandemic flu vaccine.
